Archive for April, 2010
Combination antibiotics effective against chlamydia-induced arthritis, study finds
Combination antibiotics effectively treat Chlamydia-induced immediate arthritis — a major step headed fοr management, аחԁ possibly cure, οf tһіѕ disease, a federal multicenter clinical trial һаѕ establish.
View full post οח Yahoo! News Search Consequences fοr arthritis treatment
FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing … – Yahoo! Finance: Internet Software & Services Industry News
Twenty-seven million Americans are affected by osteoarthritis(3), which is the most common form of arthritis.(4) While many patients ... enteric-coated naproxen 500 mg, twice daily, over a six-month treatment period. Endoscopies were performed at ...
View full post on arthritis treatment - Bing NewsRelated BlogsGeneric for naproxen | Garasila.spb.su musicNo prescription generic naproxen buy | Elkavan.msk.ru medical archiveCan We Justify Performing Upper and Lower Endoscopies on ...Under-treatment of Lymphoma and the Risks of Relapse | zu cancerHow long endoscopies begins to take over?Diagnosing Rheumatoid ArthritisTreatments for Rheumatoid ArthritisArthritis – Causes And Treatment For Arthritis [...]
Biotech companies return to profitability
Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia ...
Read more on News-Medical-Net
Human Genome Sciences reports net loss of $47.9M for first-quarter 2010
Human Genome Sciences, Inc. today announced financial results for the quarter ended March 31, 2010, and provided highlights [...]
New Laser Treats Fibromyalgia
BELLUS Health and Celtic Therapeutics enter agreement for BELLUS' drug candidate KIACTA(TM)
BELLUS Health and Celtic Therapeutics announced today that they have signed a final agreement pursuant to which Celtic Therapeutics will acquire and license worldwide rights related to the Phase III investigational product candidate KIACTA for upfront payments of US$10 million, and will fund 100% of KIACTA's development costs through its confirmatory Phase III clinical study and other ...
Read more on CNW Group via Yahoo! Finance
Man warns of pothole danger on road
A SUTTON on Sea man is warning others about the dangers of crossing a cracked, pot-hole ridden road after tripping and injuring himself.
Read [...]
XOMA to Announce 2010 First Quarter Financial Results and Host Webcast Conference Call on May 6
Driver who seriously injured Baldwin County deputy gets 10-year split sentence
BAY MINETTE -- A Baldwin County judge on Wednesday handed Summar Sammons Marousky a 10-year split sentence for first-degree assault in connection with a 2008 wreck that seriously injured a Baldwin County sheriff's deputy. Circuit Judge J. Langford Floyd sentenced Marousky, 29, to serve 36 months in prison, with credit given for time served. After 12 months, Floyd said he will consider whether to ...
Read more on Mobile Press-Register
Berkeley Clendar for April 30
href='http://www.berkeleyplayhouse.org'>www.berkeleyplayhouse.org.
Read more on Berkeley Voice - Albany Journal
XOMA to Announce 2010 First [...]